Case number 1:19-cv-00626
Bausch Health Ireland Limited et al v. Lupin Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2020 | 1 | Complaint (19) |
| Aug 20, 2019 | 9 | Patent/Trademark Report to Commissioner (1) |
| Aug 20, 2019 | 9 | Notice (1) |
| Aug 20, 2019 | 9 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,999,313 B2 ;9,326,969 B2 ;9,592,252 B2 ;9,707,297 B2 ;10,016,504 B2. (Attachments: # (1) Notice)(fms) |
| Aug 5, 2019 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per D.I. [8] (fms) |
| Aug 5, 2019 | 8 | Notice of Voluntary Dismissal (1) Docket Text: NOTICE of Voluntary Dismissal by Bausch Health Ireland Limited, Norgine B.V., Salix Pharmaceuticals, Inc. as to Defendants Lupin LTD., Lupin Atlantis Holdings SA, Lupin Inc., and Lupin Pharmaceuticals, Inc. (Viceconte, Christopher) |
| Jul 22, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [7] STIPULATION TO EXTEND TIME for the Defendants Lupin Ltd., Lupin Atlantis Holdings SA, Lupin Inc. and Lupin Pharmaceuticals, Inc. to answer, move or otherwise respond to the Complaint to August 21, 2019 filed by Lupin Inc., Lupin Ltd., Lupin Atlantis Holdings SA, Lupin Pharmaceuticals, Inc. Set/Reset Answer Deadlines: Lupin Atlantis Holdings SA answer due 8/21/2019; Lupin Inc. answer due 8/21/2019; Lupin Ltd. answer due 8/21/2019; Lupin Pharmaceuticals, Inc. answer due 8/21/2019. Signed by Judge Colm F. Connolly on 7/22/2019. (fms) |
| Jul 22, 2019 | 7 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the Defendants Lupin Ltd., Lupin Atlantis Holdings SA, Lupin Inc. and Lupin Pharmaceuticals, Inc. to answer, move or otherwise respond to the Complaint to August 21, 2019 - filed by Lupin Atlantis Holdings SA, Lupin Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Phillips, John) |
| Jul 1, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Lupin Atlantis Holdings SA on 7/1/2019; Lupin Inc. on 7/1/2019; Lupin Ltd. on 7/1/2019; Lupin Pharmaceuticals, Inc. on 7/1/2019. (nmg) |
| Apr 10, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nmg) |
| Apr 4, 2019 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (nmg) |
| Apr 3, 2019 | 1 | Exhibit A (36) |
| Apr 3, 2019 | 1 | Exhibit B (37) |
| Apr 3, 2019 | 1 | Exhibit C (27) |
| Apr 3, 2019 | 1 | Exhibit D (38) |
| Apr 3, 2019 | 1 | Exhibit E (37) |
| Apr 3, 2019 | 1 | Civil Cover Sheet (1) |
| Apr 3, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Apr 3, 2019 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/19/2019. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 8/19/2021. (nmg) |
| Apr 3, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,999,313 B2 ;9,326,969 B2 ;9,592,252 B2 ;9,707,297 B2 ;10,016,504 B2. (nmg) |
| Apr 3, 2019 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bausch Health Companies Inc. for Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. filed by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc.. (nmg) |
| Apr 3, 2019 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Norgine Europe B.V. for Norgine B.V. filed by Norgine B.V.. (nmg) |
| Apr 3, 2019 | 1 | Main Document (19) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Lupin Atlantis Holdings SA, Lupin Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2610661.) - filed by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc., Norgine B.V.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Civil Cover Sheet)(nmg) |
| Apr 3, 2019 | 1 | Complaint* (1) |
